Key indicators: single-crystal X-ray study; T = 293 K; mean (C-C) = 0.009 Å; disorder in main residue; R factor = 0.053; wR factor = 0.179; data-to-parameter ratio = 15.4.
The central part of the title centrosymmetric dinuclear complex, [Zn 2 (C 7 H 5 O 2 ) 4 (C 9 H 12 N 2 ) 2 ], has a paddle-wheel conformation with four benzoate ligands bridging two symmetry-related Zn II ions. The distorted square-pyramidal coordination environment around the Zn II ion is completed by an N atom from a 4-(pyrrolidin-1-yl)pyridine ligand. The ZnÁ Á ÁZn separation of 2.9826 (12) Å does not represent a formal direct metal-metal bond. The Zn II ion is displaced by 0.381 (1) Å from the mean plane of the four basal O atoms. Two of the C atoms of the pyrrolidine ring are disordered over two sites with refined occupancies of 0.53 (2) and 0.47 (2). 
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[Zn 2 (C 7 H 5 O 2 ) 4 (C 9 H 12 N 2 ) 2 ] M r = 911.59 Monoclinic, P2 1 =n a = 11.0021 (11) Å b = 11.4303 (11) 
Comment
Recently, great attention has been paid to transition metal ions as the major cation contributors to the inorganic composition of natural water and biological fluids (Daniele, et al., 2008; Parkin, 2004; Tshuva & Lippard, 2004) . Some biologically active molecules that have potential interactions with transition metal ions are amino acids, proteins, sugars, nucleotides, fulvic acids and humic acids. In particular, the study on the interaction of transition metal ions with fulvic acids and humic acids, mainly found in soil, is being extensively investigated. As models to examine these interactions we have previously used copper(II) and zinc(II) benzoates as building blocks and reported the structures of copper(II) and zinc(II) benzoates with quinoxaline, 6-methylquinoline, 3-methylquinoline, di-2-pyridylketone, andtrans-1-(2-pyridyl)-2-(4-pyridyl)ethylene (Lee, et al., 2008; Yu, et al., 2008; Park, et al., 2008; Shin, et al., 2009; Yu, et al., 2009; Song, et al., 2009 ). The related paddle-wheel type structures for Zn complexes have been previouly reported (Necefoglu, et al., 2002; Zeleňák, et al.,2004; Kamakar, et al., 2006; Ohmura, et al., 2005) . In this work, we have employed zinc(II) benzoate as a building block and 4-(pyrrolidin-1-yl)pyridine as a ligand. We report herein the structure of the title complex.
The molecular structure of the title complex is shown in Fig. 1 (7) O22-C21 i 1.268 (7) C31-H31 0.9300 N31-C35 1.329 (6) C32-C33 1.404 (7) N31-C31 1.333 (6) C32-H32 0.9300 N32-C33 1.330 (6) C33-C34 1.412 (7) N32-C39 1.454 (7) C34-C35 1.370 (7) N32-C36 1.470 (7) C34-H34 0.9300 C11-O12 i 1.270 (6) C35-H35 0.9300 C11-C12 1.500 (7) C36-C37 1.536 (7) 
